Sofia Chen

Intrinsic Clearance Assay Incubational Binding: A Method Comparison

F. Bergström, K. Grime, Pär Nordell, 2017, Drug Metabolism and Disposition.

ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma

C. Bakal, D. Adams, Francesca Butera, 2019, Nature Communications.

A screen for combination therapies in BRAF/NRAS wild type melanoma identifies nilotinib plus MEK inhibitor as a synergistic combination

Anton J. Enright, Anneliese O. Speak, A. Speak, 2017, bioRxiv.

ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma

C. Bakal, D. Adams, Francesca Butera, 2019, Nature Communications.